Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,850
Closed -$237K 215
2023
Q4
$237K Hold
6,850
0.02% 179
2023
Q3
$247K Hold
6,850
0.02% 161
2023
Q2
$257K Hold
6,850
0.02% 161
2023
Q1
$316K Hold
6,850
0.03% 155
2022
Q4
$317K Hold
6,850
0.03% 154
2022
Q3
$299K Hold
6,850
0.03% 159
2022
Q2
$290K Hold
6,850
0.02% 161
2022
Q1
$298K Hold
6,850
0.02% 170
2021
Q4
$363K Hold
6,850
0.03% 167
2021
Q3
$325K Hold
6,850
0.03% 164
2021
Q2
$311K Hold
6,850
0.02% 168
2021
Q1
$293K Hold
6,850
0.02% 167
2020
Q4
$283K Hold
6,850
0.03% 163
2020
Q3
$267K Hold
6,850
0.03% 161
2020
Q2
$250K Buy
+6,850
New +$231K 0.03% 157

Other funds holding G

S&CO Inc's G Position: Q1 2024 in Review

S&CO Inc sold out of Genpact (G) in Q1 2024, closing a stake of 6,850 shares — an estimated $237K sold.

S&CO Inc first reported a position in G in Q2 2020 and held it in 15 quarters. The position peaked at $363K in Q4 2021. 364 funds tracked by Wall St. Rank hold G as of Q1 2024.

  • S&CO Inc reported no remaining Genpact position as of Q1 2024 after selling out during the quarter.
  • S&CO Inc sold 6,850 Genpact shares in Q1 2024, an estimated $237K.
  • S&CO Inc first reported a position in Genpact in Q2 2020 and held it in 15 quarters.
  • S&CO Inc's Genpact position peaked at $363K in Q4 2021.
  • 364 funds tracked by Wall St. Rank held Genpact as of Q1 2024.

Based on S&CO Inc's 13F filing for Q1 2024, filed 9 May 2024.